Deferoxamine reverses radiation induced hypovascularity during bone regeneration and repair in the murine mandible

Bone. 2012 May;50(5):1184-7. doi: 10.1016/j.bone.2012.01.019. Epub 2012 Feb 1.

Abstract

Background: Deferoxamine (DFO) is an iron-chelating agent that has also been shown to increase angiogenesis. We hypothesize that the angiogenic properties of DFO will improve bone regeneration in distraction osteogenesis (DO) after x-ray radiation therapy (XRT) by restoring the vascularity around the distraction site.

Material and methods: Three groups of Sprague-Dawley rats underwent distraction of the left mandible. Two groups received pre-operative fractionated XRT, and one of these groups was treated with DFO during distraction. After consolidation, the animals were perfused and imaged with micro-CT to calculate vascular radiomorphometrics.

Results: Radiation inflicted a severe diminution in the vascular metrics of the distracted regenerate and consequently led to poor clinical outcome. The DFO treated group revealed improved DO bone regeneration with a substantial restoration and proliferation of vascularity.

Conclusions: This set of experiments quantitatively demonstrates the ability of DFO to temper the anti-angiogenic effect of XRT in mandibular DO. These exciting results suggest that DFO may be a viable treatment option aimed at mitigating the damaging effects of XRT on new bone formation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiography
  • Animals
  • Bone Regeneration / drug effects
  • Bone Regeneration / radiation effects*
  • Deferoxamine / pharmacology*
  • Male
  • Mandible / blood supply*
  • Mandible / drug effects*
  • Mandible / pathology
  • Mandible / radiation effects
  • Mice
  • Radiation*
  • Rats
  • Rats, Sprague-Dawley
  • Wound Healing / drug effects*
  • Wound Healing / radiation effects*
  • X-Ray Microtomography
  • X-Rays

Substances

  • Deferoxamine